Identification of microRNA that represses IRS-1 expression in liver

Kaoru Ono,Motoyuki Igata,Tatsuya Kondo,Sayaka Kitano,Yuki Takaki,Satoko Hanatani,Masaji Sakaguchi,Rieko Goto,Takafumi Senokuchi,Junji Kawashima,Noboru Furukawa,Hiroyuki Motoshima,Eiichi Araki

DOI: https://doi.org/10.1371/journal.pone.0191553

IF: 3.7

2018-01-24

PLoS ONE

Abstract:MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally regulate gene expression and have been shown to participate in almost every cellular process. Several miRNAs have recently been implicated in glucose metabolism, but the roles of miRNAs in insulin-resistant conditions, such as obesity or type 2 diabetes, are largely unknown. Herein, we focused on miR-222, the expression of which was increased in the livers of high fat/high sucrose diet-fed mice injected with gold thioglucose (G+HFHSD). Overexpression of miR-222 in primary mouse hepatocytes attenuated Akt phosphorylation induced by insulin, indicating that miR-222 negatively regulates insulin signaling. As per in silico analysis, miR-222 potentially binds to the 3' untranslated region (3' UTR) of the IRS-1 gene, a key insulin signaling molecule. In fact, IRS-1 protein expression was decreased in the livers of G+HFHSD-fed mice. We further confirmed a direct interaction between miR-222 and the 3' UTR of IRS-1 via luciferase assays. Our findings suggest that up-regulation of miR-222 followed by reduction in IRS-1 expression may be a viable mechanism of insulin resistance in the liver.

multidisciplinary sciences